CAMBRIDGE, MA, Alltrna, a company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines, has raised $109 million in a Series B financing.
Read More

BOSTON, MA, ROME Therapeutics, a biotechnology company, announced the completion of an oversubscribed $72 million Series B extension financing.
Read More